Jason, a triathlete and CoolSculpting user, is one of several actual users featured in Allergan Aesthetics' new DTC effort.
May 18, 2022 01:08 PM EDT
Pharma
Marketing

Ab­b­Vie ex­pands use of re­al pa­tients in lat­est Al­ler­gan Aes­thet­ics DTC cam­paign

Beth Snyder Bulik

Senior Editor

Ab­b­Vie’s Al­ler­gan Aes­thet­ics is en­list­ing re­al peo­ple for the first time in a new cam­paign for CoolSculpt­ing. Its lat­est push for the body fat-freez­ing sys­tem …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Vi­a­tris' In­dia-based man­u­fac­tur­ing site blocked from ship­ping 11 gener­ic drugs to US

A service from the Financial Times